Publications by authors named "Rie Ohba"

Claim this Profile
P
Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant-ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105.
Tomotaka Suzuki, Dai Maruyama, Ryunosuke Machida, Tomoko Kataoka, Noriyasu Fukushima, Rie Ohba

Hematol Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1).
Nobuhiko Nakamura, Dai Maruyama, Ryunosuke Machida, Tatsuo Ichinohe, Nobuyuki Takayama, Rie Ohba

Jpn J Clin Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma exchange combined with bortezomib-based chemotherapy is effective for early renal recovery in a patient with IgD-λ type multiple myeloma.
Hiroyuki Ueda, Hideaki Kuno, Daisuke Takahashi, Ai Katsuma, Ai Kimura, Rie Ohba

CEN Case Rep· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Outcomes of primary central nervous system lymphoma patients treated with high-dose methotrexate and rituximab].
Yuko Shiota, Nobuaki Dobashi, Yuta Ito, Rika Hosoba, Hirofumi Yamauchi, Rie Ohba

Rinsho Ketsueki· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Myelodysplastic syndrome with myelofibrosis in which azacitidine therapy was effective and cord blood transplantation was carried out].
Rie Ohba, Noriko Usui, Yuta Ito, Hirofumi Yamauchi, Tomohito Machishima

Rinsho Ketsueki· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological analysis of primary adrenal diffuse large B-cell lymphoma: effectiveness of rituximab-containing chemotherapy including central nervous system prophylaxis.
Satoshi Ichikawa, Noriko Fukuhara, Ai Inoue, Hiroki Katsushima, Rie Ohba

Exp Hematol Oncol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS).
Rie Ohba, Kazumichi Furuyama, Kenichi Yoshida, Tohru Fujiwara, Noriko Fukuhara

Ann Hematol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Management of pH-positive acute lymphoblastic leukemia].
Rie Ohba, Noriko Usui

Nihon Rinsho· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment with bortezomib and thalidomide for POEMS syndrome.
Hiroto Ohguchi, Rie Ohba, Yasushi Onishi, Noriko Fukuhara, Yoko Okitsu

Ann Hematol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin K2 modulates differentiation and apoptosis of both myeloid and erythroid lineages.
Eriko Sada, Yasunobu Abe, Rie Ohba, Yoshimichi Tachikawa, Eriko Nagasawa

Eur J Haematol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis